Farther Finance Advisors’s Structure Therapeutics GPCR Stock Holding History

Farther Finance Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$54.1K	Buy	1,730 +74	+4%	+$3.47K	﹤0.01%	3346
2026 Q2	$88.9K	Buy	1,656 +725	+78%	+$32.1K	﹤0.01%	2800
2026 Q1	$46.7K	Buy	931 +241	+35%	+$16.5K	﹤0.01%	3043
2025 Q4	$48K	Buy	690 +20	+3%	+$817	﹤0.01%	2849
2025 Q3	$18.8K	Hold	670	–	–	﹤0.01%	3091
2025 Q2	$13.9K	Buy	+670	New	+$14.7K	﹤0.01%	2895

Other funds holding GPCR

PCA

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's GPCR Position: Q3 2026 in Review

Farther Finance Advisors increased its Structure Therapeutics (GPCR) stake by 4.5% in Q3 2026, buying an estimated $3.47K and bringing the position to 1,730 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Farther Finance Advisors first reported a position in GPCR in Q2 2025 and has held it in 6 quarters since. The position peaked at $88.9K in Q2 2026. 3 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

Farther Finance Advisors held 1,730 shares of Structure Therapeutics worth $54.1K as of Q3 2026.
Farther Finance Advisors bought 74 Structure Therapeutics shares in Q3 2026, an estimated $3.47K.
Structure Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3346 holding.
Farther Finance Advisors first reported a position in Structure Therapeutics in Q2 2025 and has held it in 6 quarters since.
Farther Finance Advisors's Structure Therapeutics position peaked at $88.9K in Q2 2026.
3 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.